SOPH:NASDAQ, SOPHiA GENETICS SA

Why SOPH stock fell on November 19

SOPHiA GENETICS SA fell 10.6% on Thursday, November 19, 2026, on 1,582,128 shares, 2.4 times its average daily volume. No headline about SOPH came out that day or the day before in the news feeds we follow, so the move may come from news we don't track, the sector or trading alone.

SOPH stock overview

SOPHiA GENETICS SA (SOPH:NASDAQ) closed at $6.68 on November 19, 2026, down 10.58% on the day. The stock trades 25.6% below its 52-week high of $8.98 and 74.4% above its 52-week low of $3.83. Over the past year, it gained 71.7%. SOPHiA GENETICS SA is part of the Health Care sector.

Key figures

Price
$6.68
Day change
-10.58%
Volume
1,582,128
Average volume
657,825
Market cap
572M+
52-week range
$3.83 – $8.98
50-day average
$7.62
200-day average
$6.09

Price action over the past year

In 252 trading sessions since November 19, 2025, SOPH closed higher on 128 days (51%). Its best day was August 4, 2026 (+20.21%) and its worst was March 3, 2026 (-11.26%). The stock moved 10% or more in a single session 5 times.

Recent signals

SOPH news

About SOPHiA GENETICS SA

Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities.

Similar stocks

Find more stocks like SOPH with the Spikes, Gaps, Breakouts and Performance Tracker scanners.

Based on end-of-day data. For information only, not investment advice.